States get $853,000 in reduced fees for Shkreli antitrust cases

By Bryan Koenig (June 10, 2022, 9:05 p.m. EDT) — A federal judge in New York on Friday signed $853,440.80 in attorneys’ fees for four of the states that successfully sued “pharma bro” Martin Shkreli for an anti-competitive scheme to secure a 40x price increase for a life-saving drug, a significant reduction on the more than $2 million originally sought.

California is expected to recoup $200,272.50 while $328,803.80 will go to Illinois, $87,053 to Ohio and $237,311.50 to Pennsylvania as part of the surcharge bid submitted on May 2 and necessitated by U.S. District Judge Denise Cote’s late April order finding that if the four states — out of the seven attorneys general who…

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
  • Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and more!

TRY LAW360 FREE FOR SEVEN DAYS